Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 10, 20261,212 studies indexed

July 2026

Added to Dediabetes Jul 12, 2026RCTs

Curcuma longa extract improves neuropathy symptoms in type 2 diabetes

This study evaluated the effects of Curcuma longa extract on neuropathy symptoms and vascular biomarkers in adults with type 2 diabetes, finding significant improvements in several measures.

Interventions
Curcuma longa extract (CLE)
Outcomes
Hyaluronic acid (HA)Matrix metalloproteinase-2 (MMP-2)Matrix metalloproteinase-9 (MMP-9)+8 more
Added to Dediabetes Jul 12, 2026RCTs

Curcumin may improve inflammation and glycemic control in diabetes

Curcumin supplementation was studied for its effects on inflammatory and glycemic profiles in adults with type 2 diabetes, showing significant improvements in several key metrics.

Interventions
Curcumin supplementation
Outcomes
C-reactive proteinFasting Plasma Glucose (FPG)Glutathione peroxidase (GPx)+6 more
Added to Dediabetes Jul 12, 2026RCTs

Curcumin-Piperine May Improve Oxidative Stress in Diabetic Retinopathy

The study evaluated the effects of curcumin-piperine supplementation on oxidative stress and kidney function in diabetic retinopathy patients, finding significant improvements in antioxidant capacity and creatinine levels.

Interventions
Curcumin plus piperine
Outcomes
Blood urea nitrogen (BUN)C-reactive proteinFasting Plasma Glucose (FPG)+7 more
Added to Dediabetes Jul 12, 2026Cohort

Dapagliflozin may improve RAAS markers in diabetes patients

This study investigated the effects of dapagliflozin on the renin-angiotensin-aldosterone system in patients with type 2 diabetes, finding significant changes in several metabolic parameters.

Interventions
Dapagliflozin
Outcomes
BMIDiastolic blood pressureFasting blood sugar (FBS)+8 more
Added to Dediabetes Jul 12, 2026RCTs

Dapagliflozin improves brain function in type 2 diabetes

This study investigated the neuroprotective effects of dapagliflozin and liraglutide in patients with type 2 diabetes, highlighting distinct outcomes on brain function.

Interventions
DapagliflozinLiraglutide
Outcomes
Attention improvementMemory performanceOlfactory task functional connectivity+3 more
Added to Dediabetes Jul 12, 2026RCTs

Dapagliflozin Improves Glycemic Control with Insulin Pump Therapy

This study evaluated the addition of dapagliflozin to insulin pump therapy in patients with Type 2 diabetes, finding significant improvements in glycemic targets and insulin dosage.

Interventions
Insulin therapyMetformin
Outcomes
Assessment of pancreatic function through insulin and C-peptide levelsTime to glycemic targetTotal daily insulin dose
Added to Dediabetes Jul 12, 2026RCTs

Dapagliflozin improves metabolic outcomes in type 2 diabetes patients

This study compared the effects of dapagliflozin and vitamin E in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes, finding significant improvements in several metabolic parameters with dapagliflozin.

Interventions
Dapagliflozin
Outcomes
ASTAlanine Aminotransferase (ALT)BMI+8 more
Added to Dediabetes Jul 12, 2026RCTs

Dapagliflozin-linagliptin combo improves glycemic control and organ protection

This study evaluated the combination therapy of Dapagliflozin and Linagliptin in managing Type 2 Diabetes and hypertension, showing significant improvements in various health metrics.

Interventions
Dapagliflozin
Outcomes
Alanine Aminotransferase (ALT)Estimated glomerular filtration rateFasting Plasma Glucose (FPG)+5 more

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.